logo
Plus   Neg
Share
Email

Teva Pharmaceutical Industries Limited Q2 adjusted earnings Beat Estimates

Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):

-Earnings: -$689 million in Q2 vs. -$241 million in the same period last year.
-EPS: -$0.63 in Q2 vs. -$0.24 in the same period last year.
-Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $653 million or $0.60 per share for the period.
-Analysts projected $0.57 per share
-Revenue: $4.34 billion in Q2 vs. $4.70 billion in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT